Forest Labs vs. Icahn Approaches Showdown Tomorrow

Wednesday will mark the final stand in the latest battle between Carl Icahn and Forest Labs. At the Forest Labs annual meeting, shareholders will have to decide which side they are on and who should be running the pharmaceutical company’s board: the 35-year CEO or the noted shareholder activist.
The Wall Street Journal